Clinical and Immunomodulatory Effects of Combination Immunotherapy with Low- Dose Interleukin 2 and Tumor Necrosis Factor a. in Patients with Advanced Non-Small Cell Lung Cancer: A Phase I Trial

Stephen C. Yang, Elizabeth A. Grimm, David R. Parkinson, Judith Carinhas, Kim D. Fry, Ana Mendiguren-Rodriguez, Jere Licciardello, Laurie B. Owen-Schaub, Waun K. Hong, Jack A. Roth

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical and Immunomodulatory Effects of Combination Immunotherapy with Low- Dose Interleukin 2 and Tumor Necrosis Factor a. in Patients with Advanced Non-Small Cell Lung Cancer: A Phase I Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences